Search

Introduction: The only way to limit the prevalence of COVID-19 is to adhere strictly to health protocol. In this regard, WHO has provided the information needed to prevent and deal with this disease on its website. To investigate the Impact of Internet Health Information on Adherence to COVID-19 Protocols, in Iran. Material and Methods: This is a cross-sectional survey and structural equation modeling which is done by students of at the Kerman University of Medical Science, Iran. The data collection tool was a questionnaire. SPSS 22.0, and SmartPLS 3software were used to analyze the data. Results: The present study investigated the impact of health information on the WHO website on adherence to COVID-19 protocols among the students of the Kerman University of Medical Sciences. The bootstrapping results indicate relationships between health information seeking constructs and information quality, satisfaction, and reputation. Regarding the other six hypotheses in the present study, it is predicted that they will be rejected in a larger sample. Conclusion: Online information is now available more easily, quickly, and at a lower cost compared to other sources, it should be constantly monitored and constantly improved in quality. Its usefulness, ease of use, accuracy, recency, and simplicity should be constantly investigated. [ABSTRACT FROM AUTHOR]

Introduction: Epidemic diseases have always caused considerable physical and financial casualties for governments. By the end of the year 2019, the Covid19 pandemic emerged for the first time in China and rapidly infected the globe. Objectives: As information technology plays a significant role in the current healthcare system, the aim of the present study was to conduct a systematic review to determine the role of electronic health in the Covid19 crisis. Material and Methods: This review was carried out on articles published from December 2019 until March 17th 2020 by searching keywords and their equivalents in "MeSH" in PubMed, Web of Science, and Scopus databases and Google search engine. Results: In total, from 72 found articles, 28 were recognized based on their research topic. After imposing inclusion and exclusion criteria, eventually 6 original articles and 8 reports were selected for further analysis. Results showed that reviewed articles had mentioned the effective role of IT in: diagnosing Corona patients, addressing the spread of the disease, providing sufficient education for the public to prevent the disease, and recognizing high-risk areas. Telemedicine, machine learning algorithms, deep learning, Augmented intelligence, neural networks, Global positioning system, and geographical information system have been the most widely used technologies. Conclusion: It was shown that defeating the Covid19 is impossible without the help of technology. Experiences with the effectivity of using electronic health in controlling and monitoring the prevalence of Covid19 can be used to deal with other pandemic diseases in the future as well; and to avoid possible casualties and economic regressions while rapidly providing solutions for similar critical situations. [ABSTRACT FROM AUTHOR]

Concerns about the prevention and management of COVID-19 are on the rise, as it is crucial in contagious epidemics that travel and transfer of the patients be minimal for diagnosis, treatment, and follow-ups. Telemedicine or telehealth can play an important role, especially with previous successful experiences in the management of acute infectious respiratory epidemics such as SARS and MERS. In order to better control the rapid spread of coronavirus and manage the COVID-19 crisis, both developed and developing countries can improve the efficiency of their health system by replacing a proportion of face-to-face clinical encounters with telehealth. Recent technological advancement facilitates this reform, but there is a need for national or state-wide rules and regulations to be adapted accordingly. [ABSTRACT FROM AUTHOR]

Background: With the spread of Covid-19 disease, health interventions related to the control, prevention, and treatment of this disease and other diseases were given real attention. The purpose of this systematic review is to express facilitators and barriers of using mobile health (mHealth) interventions during the Covid-19 pandemic. Methods: In this systematic review, original studies were searched using keywords in the electronic database of PubMed until August 2022. The objectives and outcomes of these studies were extracted. Finally, to identify the facilitators and barriers of mHealth interventions, a qualitative content analysis was conducted based on the strengths, weaknesses, opportunities, and threats (SWOT) analysis method with Atlas.ti 8 software. We evaluated the studies using the Mixed Methods Appraisal Tool (MMAT). Results: In total, 1598 articles were identified and 55 articles were included in this study. Most of the studies used mobile applications to provide and receive health services during the Covid-19 pandemic (96.4%). The purpose of the applications was to help prevention (17), follow-up (15), treatment (12), and diagnosis (8). Using SWOT analysis, 13 facilitators and 18 barriers to patients' use of mHealth services were identified. Conclusion: Mobile applications are very flexible technologies that can be customized for each person, patient, and population. During the Covid-19 pandemic, the applications designed due to lack of interaction, lack of time, lack of attention to privacy, and non-academic nature have not met their expectations of them. [ABSTRACT FROM AUTHOR]

Background: Following the coronavirus disease 2019 (COVID-19) pandemic, the health authorities recommended the implementation of strict social distancing and complete lockdown regulations to reduce disease spread. The pharmacists quickly adopted telemedicine (telepharmacy) as a solution against this crisis, but awareness about this technology is lacking. Therefore, the purpose of this research was to explore the patients' perspectives and preferences regarding telepharmacy instead of traditional in-person visits. Methods: An electronic questionnaire was designed and sent to 313 patients who were eligible for the study (from March to April 2021). The questionnaire used five-point Likert scales to inquire about motivations for adopting telepharmacy and in-person visits, their perceived advantages and disadvantages, and the declining factors of telepharmacy. Finally, the results were descriptively analyzed using SPSS 22. Results: Of all 313 respondents, a total of 241 (77%) preferred appointments via telepharmacy while 72 (23%) preferred in-person services. There was a significant difference between the selection percentage of telepharmacy and in-person services (chi-square 91.42; p < 0.0001). Preference bout the telepharmacy system versus in-person visits to the pharmacy was associated with factors such as "reducing the incidence of contagious disease" (4.41; ± 0.78), "spending less time receiving pharmaceutical services" (4.24; ± 0.86)), and "traveling a shorter distance for receiving pharmaceutical services" (4.25; ± 0.86). "Reducing costs" (90.87%), "saving time" (89.21%), and "reducing the incidence of contagious disease" (87.13%) were the most important reasons for choosing telepharmacy services. Also, "face-to-face communication with the pharmacist" (25%), "low internet bandwidth" (25%), and "reduction of patients' anxiety and the increase of their peace of mind" (23.61%) were the most important reasons for choosing in-person visits. Conclusion: Survey data indicate that most participants are likely to prefer the use of telepharmacy, especially during crises such as the current COVID-19 pandemic. Telepharmacy can be applied as an important means and a crucial service to lessen the load on healthcare organizations and expand drug supply shelters in pharmacies. However, there are still substantial hurdles to overcome in order to successfully implement the telemedicine platform as part of mainstream practice. [ABSTRACT FROM AUTHOR]

Background: Following the coronavirus disease 2019 (COVID-19) pandemic, the health authorities recommended the implementation of strict social distancing and complete lockdown regulations to reduce disease spread. The pharmacists quickly adopted telemedicine (telepharmacy) as a solution against this crisis, but awareness about this technology is lacking. Therefore, the purpose of this research was to explore the patients' perspectives and preferences regarding telepharmacy instead of traditional in-person visits. Methods: An electronic questionnaire was designed and sent to 313 patients who were eligible for the study (from March to April 2021). The questionnaire used five-point Likert scales to inquire about motivations for adopting telepharmacy and in-person visits, their perceived advantages and disadvantages, and the declining factors of telepharmacy. Finally, the results were descriptively analyzed using SPSS 22. Results: Of all 313 respondents, a total of 241 (77%) preferred appointments via telepharmacy while 72 (23%) preferred in-person services. There was a significant difference between the selection percentage of telepharmacy and in-person services (chi-square 91.42; p < 0.0001). Preference bout the telepharmacy system versus in-person visits to the pharmacy was associated with factors such as "reducing the incidence of contagious disease" (4.41; ± 0.78), "spending less time receiving pharmaceutical services" (4.24; ± 0.86)), and "traveling a shorter distance for receiving pharmaceutical services" (4.25; ± 0.86). "Reducing costs" (90.87%), "saving time" (89.21%), and "reducing the incidence of contagious disease" (87.13%) were the most important reasons for choosing telepharmacy services. Also, "face-to-face communication with the pharmacist" (25%), "low internet bandwidth" (25%), and "reduction of patients' anxiety and the increase of their peace of mind" (23.61%) were the most important reasons for choosing in-person visits. Conclusion: Survey data indicate that most participants are likely to prefer the use of telepharmacy, especially during crises such as the current COVID-19 pandemic. Telepharmacy can be applied as an important means and a crucial service to lessen the load on healthcare organizations and expand drug supply shelters in pharmacies. However, there are still substantial hurdles to overcome in order to successfully implement the telemedicine platform as part of mainstream practice. [ABSTRACT FROM AUTHOR]

Introduction: The epidemic of viral respiratory diseases in the last 20 years has affected many people around the world. In these situations, telemedicine may reduce unnecessary contacts and the risk of exposure to infection. This study aimed to review the papers performed to manage viral respiratory disease epidemics using telemedicine. Material and Methods: The PubMed and Scopus databases were searched in May 2020 for this systematic review study. Data were extracted from the final included papers based on the author, country, type of epidemic, telemedicine modality, telecommunication method, objective, participants, clinical outcome, cost, and satisfaction. Descriptive statistics were used to analyze data. Results: From 365 retrieved papers, 18 papers were included. Most of the papers were done in the US and China (67%). Half of the papers were done during the COVID-19 pandemic. Real-time modality was used in 78% of the papers. The telecommunication method in half of the papers was internetbased. Patients’ management and treatment was the main objective of the six papers. In 81% of the teleconsultation papers, the consultation was performed between patients and healthcare providers. The clinical outcome of all papers showed that telemedicine was successful in the management of viral respiratory disease epidemics. Cost and satisfaction outcomes were considered in a few papers. Conclusion: There is considerable evidence to show that telemedicine is a useful and convenient method to manage and control viral respiratory disease epidemics. Therefore, countries should pay special attention to telemedicine to control the current pandemic and future epidemics and use it extensively. [ABSTRACT FROM AUTHOR]

Introduction: Access to healthcare services for patients with Alzheimer's disease (AD) was limited during the COVID-19 pandemic. A mobile application (app) can help overcome this limitation for patients and caregivers. Our study aims to develop and evaluate an app to help caregivers of patients with AD during COVID-19. Methods: The study was performed in three steps. First, a questionnaire of features required for the app design was prepared based on the interviews with caregivers of AD patients and neurologists. Then, questionnaire was provided to neurologists, medical informatics, and health information management specialists to identify the final features. Second, the app was designed using the information obtained from the previous phase. Third, the quality of the app and the level of user satisfaction were evaluated using the mobile app rating scale (MARS) and the questionnaire for user interface satisfaction (QUIS), respectively. Results: The number of 41 data elements in four groups (patient's profile, COVID-19 management and control, AD management and control, and program functions) were identified for designing the app. The quality evaluation of the app based on MARS and user satisfaction evaluation based on QUIS showed the app was good. Conclusion: This is the first study that focused on developing and evaluating a mobile app for assisting Alzheimer's caregivers during the COVID-19 pandemic. As the app was designed based on users' needs and covered both information about AD and COVID-19, it can help caregivers perform their tasks more efficiently. [ABSTRACT FROM AUTHOR]

The expansion of mobile health apps for the management of COVID-19 grew exponentially in recent months. However, no study has evaluated these apps. The objective of this study was to develop a reliable measure and rate the quality of COVID-19 mobile health apps, to eventually provide a roadmap for future mHealth app development. In this study, we used COVID-related keywords to identify apps for iOS and Android devices. 13 apps (13.5% of the total number of apps identified) were selected for evaluation. App quality was assessed independently using MARS by two reviewers. Search queries yielded a total of 97 potentially relevant apps, of which 13 met our final inclusion criteria. Kendall's coefficient of concordance value for the inter-rater agreement was 0.93 (p =.03). COVID-19 GOV PK app had the highest average MARS score (4.7/5), and all of the apps had acceptable MARS scores (> 3.0). This study suggests that most COVID-related apps meet acceptable criteria for quality, content, or functionality, and they must highlight esthetic and interesting features for overall quality improvement to be welcomed by users. [ABSTRACT FROM AUTHOR]